New Formulation and Delivery Systems
for Biologic Drugs
A manufacturer seeking to acquire new drug-delivery technology. How large is the addressable market opportunity? How would the manufacturer monetize the technology capability? What business models are feasible?
Bioprocessing company seeking to extend their drug delivery capability through the acquisition of a new delivery technology wanted a third-party opinion on acquisition
In-depth interviews with industry experts, development of bottoms-up market model, and company analyses to understand the potential market and business models for the technology and path to market
Addressable market opportunity for the specific class of drug delivery
Industry feedback on the potential timing and competitive environment for drug delivery platform
New business model and capability assessment for market acceptance and success